A Comparative Study on Serum Adenosine Deaminase Level in Type 2 Diabetes Mellitus with Renal Failure Patients
Author(s): D Hemalatha, J Manjula Devi and PR Kalaiselvi*
Chronic renal failure occurs on the stage in which the kidney is not capable of removing the toxic body fluids and wastes inadequately. Chronic kidney failure is irreversible, and will eventually lead to total kidney failure, also known as end stage renal disease (ESRD). The carbohydrates play an important role in maintaining the kidney’s functions. Glycated hemoglobin (hemoglobin A1c, HbA1c , A1C, or Hb1c )is a form of hemoglobin that is measured primarily to identify the average plasma glucose concentration over prolonged periods of time. The present study was aimed to find the level of Serum Adenosine deaminase (ADA) among the patients with type 2 diabetes mellitus with chronic kidney failure. All the biochemical study parameters were analysed using Statistical Product and Service Solutions (SPSS) 17 software. Statistical tests used were Descriptives, Student t test & Pearson’s Correlation. *P < .05 is significant. **P < .001 is strongly significant. Positive correlation of ADA with chronic kidney failure in D2T patients provided that ADA could be considered for the treatment regime.